Intestinally Targeted Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitors Robustly Suppress Postprandial Triglycerides
Michael H. Serrano‐Wu(Broad Institute), Brian K. Hubbard(Broad Institute), Erik C. Rocheford, Tara Mullarkey, Alan D. Neubert, Marlene J. Juedes, Thomas Daniels, Ying Hou(First Affiliated Hospital of Henan University), Moo Je Sung, Andrew R. Tyler, Renee Commerford, Theresa Cosker, Yongjin Gong, Lisha Li(Jilin University), Qing Yang(Nanjing Medical University), Tae‐young Yoon(Dong-A ST (South Korea)), Monish Jain, Kevin B. Clairmont, Gary M. Coppola, Ricardo E. Chatelain
Cited by 27
Related Papers
Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
|Nature|2010|940
Identification of Hepatitis C Virus NS5A Inhibitors
|Journal of Virology|2009|196
Specific Inhibition of Hormone-Sensitive Lipase Improves Lipid Profile while Reducing Plasma Glucose
|Journal of Pharmacology and Experimental Therapeutics|2005|87
Inhibitors of HCV NS5A: From Iminothiazolidinones to Symmetrical Stilbenes
|ACS Medicinal Chemistry Letters|2011|86